Dr. Berchem serves as the vital conduit between the Luxembourg Institute of Health (LIH) and frontline clinical practice, specializing in the translation of functional molecular data into actionable oncology strategies.

Academic Titles & Degrees: MD (Université Libre de Bruxelles); PhD (Paris-Sud University/Gustave Roussy); Postdoctoral Fellowship (Lombardi Comprehensive Cancer Center, Georgetown University).

Current Executive & Clinical Appointments:  Head of the Department of Hemato-Oncology at Centre Hospitalier de Luxembourg; Associate Medical Director at the Luxembourg Institute of Health (LIH); Honorary Professor of Medical Oncology at the University of Luxembourg; President of the Institut National du Cancer (INC).

Research Axes & Leadership: Governance of over 50 clinical trials across lung cancer, melanoma, myeloma, and urological tumors. His recent research includes personalized functional profiling in spheroids for metastatic colorectal cancer and the investigation of anti-PD-1 immunotherapy via the Ackr2 receptor in melanoma.

Legacy Journals: